Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue Suppl 3
426 MK-3475-U02: Phase 1/2 study of investigational agents with or without pembrolizumab versus pembrolizumab monotherapy in melanoma
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and young investigator award abstracts
Clinical trials in progress
426 MK-3475-U02: Phase 1/2 study of investigational agents with or without pembrolizumab versus pembrolizumab monotherapy in melanoma
Online download statistics by month:
Online download statistics by month: November 2020 to September 2024
Abstract
Full
Pdf
Nov 2020
243
0
21
Dec 2020
43
0
15
Jan 2021
26
0
2
Feb 2021
16
0
3
Mar 2021
46
0
10
Apr 2021
54
0
3
May 2021
7
0
4
Jun 2021
0
0
9
Jul 2021
0
0
4
Aug 2021
0
0
10
Sep 2021
0
0
3
Oct 2021
68
0
24
Nov 2021
30
0
14
Dec 2021
16
0
4
Jan 2022
38
0
4
Feb 2022
22
0
0
Mar 2022
70
0
5
Apr 2022
74
0
3
May 2022
138
0
4
Jun 2022
66
0
15
Jul 2022
38
0
4
Aug 2022
54
0
7
Sep 2022
58
0
3
Oct 2022
64
0
3
Nov 2022
54
0
4
Dec 2022
50
0
11
Jan 2023
38
0
9
Feb 2023
34
0
5
Mar 2023
32
0
4
Apr 2023
32
0
6
May 2023
24
0
3
Jun 2023
32
0
4
Jul 2023
28
0
6
Aug 2023
54
0
11
Sep 2023
40
0
4
Oct 2023
40
0
4
Nov 2023
66
0
5
Dec 2023
90
0
8
Jan 2024
34
0
6
Feb 2024
40
0
5
Mar 2024
38
0
7
Apr 2024
46
0
15
May 2024
66
0
2
Jun 2024
34
0
3
Jul 2024
38
0
6
Aug 2024
42
0
4
Sep 2024
28
0
3
Total
2151
0
309
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?